With the Increasing prevalence of chronic diseases and the rising fatality rates of disorders such as CVD, CHD, Stroke, Cancer, and other heart conditions, the in-vitro diagnostics market is witnessing a boost in innovation, manufacturing capabilities, and supply chain processes. At the same time, the vigorous government contributions, as well as company approaches, are also supporting the growth of the in-vitro diagnostics market. In light of this, many companies are striving to develop newer concepts and theories for diagnosing chronic ailments using in-vitro diagnostics.
Recent developments made in in-vitro diagnostic solutions have been prolific for end-users as well as companies and manufacturers. A prime example would be the surge in geriatric patients opting for in-vitro diagnostics over other avenues due to its enhanced portability factor. In addition to geriatrics, in-vitro diagnostics help treat severe chronic ailments, bowel disorders, and muscle and joint injuries, wherein physical movements are limited.
The in-vitro diagnostics (IVD) lab stands at the centre of clinical decision-making due to its critical role in data generation. And with several leading studies highlighting the impact of AI in the management of data sets and extraction of critical insights, the IVD space is expected to change in the coming years dramatically. To help healthcare organisations select the best IVD vendors, MD Tech Review’s editorial board has narrowed down a list of IVD solution providers that are at the forefront of innovative technologies and intuitive strategies.
We present to you the ‘Top 5 In-Vitro Diagnostic Solution Providers in the UK – 2020.’
